Venture Life Group Plc (VLG)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Venture Life Group Plc (VLG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013380
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The company’s product range and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin. It also offers development and manufacturing services to companies in the medical device and cosmetic sectors. Venture Life conducts research in the therapeutic areas of cardiovascular, neurology, dermatology, rheumatology and ophthalmology. The company markets its products in the UK and abroad. Venture Life is headquartered in Bracknell, the UK.

Venture Life Group Plc (VLG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Venture Life Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Venture Life Group Plc, Medical Devices Deals, 2011 to YTD 2017 9
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
OptiBiotix Health Enters into an Agreement with Venture Life 11
Venture Life Enters into Distribution Agreement with DEEF Pharma 12
Venture Life Enters into Distribution Agreement with Hikma Pharma 13
Venture Life Enters into Distribution Agreement with Pharma Deen 14
Venture Life Enters into Distribution Agreement with Moorfields Pharma 15
Equity Offering 16
Venture Life Group Raises USD9 Million in IPO 16
Acquisition 17
Venture Life Group Acquires Biokosmes 17
Venture Life Group Plc – Key Competitors 18
Venture Life Group Plc – Key Employees 19
Venture Life Group Plc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Venture Life Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Venture Life Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Venture Life Group Plc, Deals By Therapy Area, 2011 to YTD 2017 8
Venture Life Group Plc, Medical Devices Deals, 2011 to YTD 2017 9
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
OptiBiotix Health Enters into an Agreement with Venture Life 11
Venture Life Enters into Distribution Agreement with DEEF Pharma 12
Venture Life Enters into Distribution Agreement with Hikma Pharma 13
Venture Life Enters into Distribution Agreement with Pharma Deen 14
Venture Life Enters into Distribution Agreement with Moorfields Pharma 15
Venture Life Group Raises USD9 Million in IPO 16
Venture Life Group Acquires Biokosmes 17
Venture Life Group Plc, Key Competitors 18
Venture Life Group Plc, Key Employees 19
Venture Life Group Plc, Subsidiaries 20

★海外企業調査レポート[Venture Life Group Plc (VLG)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tisza Chemical Group Public Limited Company (TVK):企業概要、財務及び戦略的SWOT分析
    Summary Tisza Chemical Group Public Limited Company (Tisza Chemical) is a chemical product manufacturer. The company produces and sells olefin and polymers. Its products include low density polyethylene, HDPE middle and high density polyethylene, PP polypropylene, and others. Tisza Chemical also pro …
  • Biofarm S.A. (BIO):企業の財務及び戦略的SWOT分析
    Summary Biofarm S.A. (Biofarm) is a pharmaceutical company that offers food supplements. The company develops and markets medicines, dietary supplements and generic products. Its products include aspirin, ambroxol, anghirol forte, anghirolbio, potent apilarnil, ascolecitin, asorian, aspablod, betaca …
  • Karrie International Holdings Limited (1050):企業の財務及び戦略的SWOT分析
    Summary Karrie International Holdings Limited (Karrie) is a mechanical parts manufacturing company that manufactures and sells personal computer and server casings, office automation products and moulds. The company’s products include computer and server casings, office automation products, moulds p …
  • Mississippi Power Company:企業のM&A・提携動向(発電分野)
    Summary Mississippi Power Company (MPC), a subsidiary of the Southern Company, is an integrated energy utility that carries out the generation and purchase of electricity and its transmission, distribution and sale. The company generates electricity using coal and gas as sources of energy. It conduc …
  • Air New Zealand Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Air New Zealand Limited Mergers …
  • ITE (Holdings) Limited (8092):企業財務及び戦略的SWOT分析
    Summary ITE (Holdings) Limited (ITE) is a technology consulting company that offers IT solutions. The company provides products such as evaluation kits, PDA, hand held terminals, access control systems and others. Its IT services comprise software application design, development and implementation, …
  • Cynosure, Inc. (CYNO):企業財務及び戦略的SWOT分析
    Summary Cynosure, Inc. (Cynosure) develops, manufactures and markets aesthetic and medical treatment systems. The company’s light-based aesthetic treatment systems are used in the treatment of skin revitalization and scar reduction, hair removal, gynecology, pigmentation, tattoo removal, wrinkle red …
  • LeMaitre Vascular Inc (LMAT)-医療機器分野:企業M&A・提携分析
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular proc …
  • Greystone Logistics, Inc. (GLGI):企業の財務及び戦略的SWOT分析
    Summary Greystone Logistics, Inc. (Greystone Logistics) is a chemical company that offers plastic products manufacturing services. The company designs, manufactures, sells and leases plastic pallets. Its plastic pallet products are used to provide logistical solutions to a various industries. Greyst …
  • Tohoku Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Ignyta Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc, a subsidiary of F. Hoffmann-La Roche Ltd, is a cancer care service provider. The company discovers, develops and commercializes new drugs targeting activated genes in cancer cells. It develops products using integrated therapeutic technology (Rx/Dx). …
  • H.C. Starck GmbH:企業の戦略的SWOT分析
    H.C. Starck GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Singapore Petroleum Company Limited:企業の戦略的SWOT分析
    Singapore Petroleum Company Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Victory Industriebeteiligung AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Victory Industriebeteiligung AG …
  • Zebra Technologies Corp.の企業概要及び財務/SWOT分析
    Zebra Technologies Corp. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Zebra Technologies Corp. annual and quarterly forecasts made by stock market experts. The report also …
  • Win Hanverky Holdings Limited (3322):企業の財務及び戦略的SWOT分析
    Summary Win Hanverky Holdings Limited (Win Hanverky) is a sportswear company that manufactures, distributes, and retails renowned sports and fashion brands. The company operates through business line such as manufacturing business, and distribution and retail business. It manufactures sportswear and …
  • Indoco Remedies Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Indoco Remedies Limited Mergers …
  • Valeant Pharmaceuticals International, Inc.:企業の戦略・SWOT・財務情報
    Valeant Pharmaceuticals International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Valeant Pharmaceuticals International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • SK Communications Co., Ltd. (066270):企業の財務及び戦略的SWOT分析
    Summary SK Communications Co., Ltd. (SKC), a subsidiary of SK Telecom Co., Ltd. is a technology company that provides internet related services. The company provides web portal search engine services. It operates nate, which offers services such as multimedia content search, intelligence news system …
  • Agios Pharmaceuticals, Inc. (AGIO):企業概要、財務及び戦略的SWOT分析
    Summary Agios Pharmaceuticals, Inc. (Agios) is a biopharmaceutical company. The company discovers and develops therapeutics in the field of cancer metabolism. Its services include such as treatment of cancer, research and development. Agios develops drugs focusing on glycolysis, fatty acid metabolis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆